Teva target 2024
Teva target 2024
Teva target 2024
Teva target 2024
Teva target 2024
Teva target 2024

Teva target 2024

Teva target 2024, Teva Pharmaceutical Industries Ltd and Sanofi Join to Develop 2024

$57.00

SKU: 7461496

Colour
  • New York Opioid Trial Allergan Settlement Leaves Teva as Last
  • Teva s CGRP Inhibitor Reduced Monthly Migraine Days in Late Stage
  • Teva Pharmaceutical analysts boost target price as brand
  • Teva Up on NYSE Following Morgan Stanley Stock Recommendation
Out of stock
Personalised:
: ( x )
Personalisation:
Edit
Remove Personalisation
Frasers Plus

Buy now.

Pay later.

Earn rewards

Representative APR: 29.9% (variable)

Credit subject to status. Terms apply.

Missed payments may affect your credit score

FrasersPlus